Dual-scale categorization based deep learning to evaluate programmed cell death ligand 1 expression in non-small cell lung cancer

In precision oncology, immune check point blockade therapy has quickly emerged as novel strategy by its efficacy, where programmed death ligand 1 (PD-L1) expression is used as a clinically validated predictive biomarker of response for the therapy. Automating pathological image analysis and accelera...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiangyun, Chen, Peilin, Ding, Guangtai, Xing, Yishi, Tang, Rongrong, Peng, Chaolong, Ye, Yizhou, Fu, Qiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4100
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137090/
https://www.ncbi.nlm.nih.gov/pubmed/34011092
http://dx.doi.org/10.1097/MD.0000000000025994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137090/
https://www.ncbi.nlm.nih.gov/pubmed/34011092
http://dx.doi.org/10.1097/MD.0000000000025994

Ejemplares similares